Site Registration
Registration benefits include:
- Access to CME/CE programs
- Free subscription to Current Medical Evidence
- Reminders of new CME/CE activities
Have a question for our experts?
Fill out the form below, and we will forward your queston to our panel of experts. We will post faculty responses in the Ask the Expert section.
Matthew R. Smith, MD, PhD
Associate Professor of Medicine
Harvard Medical School
Massachusetts General Hospital Cancer Center
Boston, Massachusetts
Matthew R. Smith earned a doctorate and a medical degree at Duke University School of Medicine in Durham, North Carolina. He completed an internship and residency in internal medicine at Brigham and Women’s Hospital, a clinical fellowship in medical oncology at the Dana-Farber Cancer Institute, and a postdoctoral fellowship in molecular biology at the Massachusetts Institute of Technology. Dr. Smith serves as Associate Professor of Medicine at Harvard Medical School, Associate Physician at Massachusetts General Hospital, and Director of The Claire & John Bertucci Center for Genitourinary Cancers.
An American Board of Internal Medicine Diplomate in both internal medicine and medical oncology, Dr. Smith holds membership in several professional societies, including the American Society for Bone and Mineral Research and the American Society for Clinical Investigation.
Dr. Smith has authored numerous articles, reviews, chapters, editorials, and clinical communications. He is on the editorial board of Clinical Cancer Research and is the Genitourinary Section Editor of Oncologist. Active in medical education, Dr. Smith conducts Medical Resident Reports and Medical Housestaff Lectures at Massachusetts General Hospital and gives regional, national, and international lectures on topics relating to the skeletal complications of prostate, bladder, and other cancers. Dr. Smith’s research on the adverse effects of gonadal steroid deficiency in prostate cancer survivors has helped define the mechanisms of treatment-related osteoporosis, diabetes, and cardiovascular disease. He is currently involved in clinical trials evaluating novel strategies of preventing treatment-related fractures and preventing and treating bone metastases in men with advanced prostate cancer.
